Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe
POST-MARKETING SURVEILLANCE TO OBSERVE SAFETY AND EFFICACY OF XYNTHA SOLOFUSE PREFILLED SYRINGE
Sponsor: Pfizer
This observational or N/A phase trial investigates Autosomal Hemophilia A and Classic Hemophilia and is currently completed. Pfizer leads this study, which shows 14 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2023 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2023 [monthly]
Completed
-
May 2019 — Jan 2021 [monthly]
Completed
▶ Show 9 earlier versions
-
Dec 2018 — May 2019 [monthly]
Completed
-
Aug 2018 — Dec 2018 [monthly]
Completed
-
Jun 2018 — Aug 2018 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Oct 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
-
Aug 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
-
Apr 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
Status: Not Yet Recruiting → Active Not Recruiting
-
Feb 2017 — Apr 2017 [monthly]
Not Yet Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.